IP Library Granted Patent US 6,972,331
Granted Patent B2
US 6,972,331 · App. 10/420,757 · Granted Dec 6, 2005

Carboxy pyrrole, process of preparing and use as precursor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,972,331
App. No.
10/420,757
Granted
Dec 6, 2005
Kind
B2
Abstract

4-Oxo-4,5-dihydro-3H-pyrrolo[3,2-d] pyrimidine-7-carboxylic acid methyl ester and process for preparing are provided. The process for producing the 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d]pyrimidine-7-carboxylic acid methyl ester comprises condensing 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester with formamidine acetate. The 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d]pyrimidine- 7-carboxylic acid methyl ester is useful as a precusor for providing 9-deaza-hypoxanthine, a key intermediate for producing certain PNP inhibitors.

Claims (22)

1. 4-Oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid methyl ester.

2. A process for producing 4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid methyl ester which comprises condensing 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester with formamidine acetate.

3. The process of claim 2 wherein the condensing is carried out under heat in the pressure of a diluent.

4. The process of claim 3 wherein the diluent is an alcohol.

5. The process of claim 4 wherein the alcohol is ethanol.

6. The process of claim 2 wherein the 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester is obtained by reacting a dialkylaminomalonate or salt thereof with a 2-cyano 3-ethoxy acrylic acid alkyl ester, and a methoxylating agent.

7. The process of claim 6 wherein the dialkylaminomalonate or salt thereof is diethylaminomalonate or salt thereof.

8. The process of claim 7 wherein the 2-cyano-3-alkoxy-acrylic acid alkyl ester is 2-cyano-3-ethoxy-acrylic acid ethyl ester.

9. The process of claim 6 wherein the 2-cyano-3-alkoxy-acrylic acid alkyl ester is 2-cyano-3-ethoxy-acrylic acid ethyl ester.

10. A process for producing 3,5-dihydropyrrolo[3,2-d]pyrimidine-4-one which comprises saponifying and then decarboxylating 4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid methyl ester.

11. The process of claim 10 wherein the saponifying is carried out employing an alkali metal hydroxide.

12. The process of claim 11 wherein the alkali metal hydroxide is KOH.

13. The process of claim 10 wherein the pH is adjusted by adding a weak acid for the decarboxylating.

14. The process of claim 13 wherein said acid is acetic acid.

15. The process of claim 10 wherein the 4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid methyl ester is obtained by condensing 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester with formamidine acetate.

16. The process of claim 15 wherein the condensing is carried out under heat in the pressure of a diluent.

17. The process of claim 16 wherein the diluent is an alcohol.

18. The process of claim 17 wherein the alcohol is ethanol.

19. The process of claim 10 wherein the 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester is obtained by reacting a dialkylaminomalonate or salt thereof with a 2-cyano-3-alkoxy-acrylic acid alkyl ester, and a methoxylating agent.

20. The process of claim 19 wherein the dialkylaminomalonate or salt thereof is diethylaminomalonate or salt thereof.

21. The process of claim 20 wherein the 2-cyano-3-alkoxy-acrylic acid alkyl ester is 2-cyano-3-ethoxy-acrylic acid ethyl ester.

22. The process of claim 19 wherein the 2-cyano-3-alkoxy-acrylic acid alkyl ester is 2-cyano-3-ethoxy-acrylic acid ethyl ester.

Assignments (5)
RELEASE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
RELEASE OF SECURITY INTEREST Recorded Apr 6, 2023
From: MIDCAP FINANCIAL TRUST
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 063348/0762 →
SECURITY INTEREST Recorded Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
RELEASE OF SECURITY INTEREST Recorded Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
SECURITY INTEREST Recorded Sep 26, 2016
From: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039858/0967 →